Reported adverse events in studies involving NMOSD, MOG antibody-positive patients included an infusion reaction (n = 1), high cholesterol (n = 1), hypertriglyceridemia (n = 1), and tooth infections (n =1) [39],[41],[43]. This evidence concerns the gene MOG and hypertriglyceridemia.